Strs Ohio Amicus Therapeutics, Inc. Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 8,900 shares of FOLD stock, worth $95,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,900

Previous 12,500 28.8%

Holding current value

$95,319

Previous $147,000 40.14%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$9.04 - $11.75 $32,543 - $42,300	-3,600 Reduced 28.8%	8,900 $88,000
Q1 2024 May 13, 2024	SELL	$11.43 - $14.24 $54,864 - $68,352	-4,800 Reduced 27.75%	12,500 $147,000
Q4 2023 Jan 30, 2024	SELL	$9.97 - $14.52 $534,392 - $778,272	-53,600 Reduced 75.6%	17,300 $245,000
Q3 2023 Oct 26, 2023	SELL	$11.78 - $13.86 $12,958 - $15,246	-1,100 Reduced 1.53%	70,900 $862,000
Q2 2023 Jul 31, 2023	SELL	$10.72 - $13.3 $204,752 - $254,030	-19,100 Reduced 20.97%	72,000 $904,000
Q1 2023 Aug 02, 2023	BUY	$10.91 - $13.54 $208,381 - $258,613	19,100 Added 26.53%	91,100 $1.01 Million
Q1 2023 Apr 27, 2023	BUY	$10.91 - $13.54 $381,850 - $473,899	35,000 Added 62.39%	91,100 $1.01 Million
Q3 2022 Oct 27, 2022	BUY	$9.82 - $12.75 $438,954 - $569,925	44,700 Added 392.11%	56,100 $585,000
Q2 2022 Jul 25, 2022	BUY	$6.23 - $11.12 $71,022 - $126,767	11,400 New	11,400 $122,000
Q1 2021 Apr 23, 2021	SELL	$9.2 - $23.86 $778,319 - $2.02 Million	-84,600 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$13.47 - $24.89 $338,097 - $624,739	25,100 Added 42.18%	84,600 $1.95 Million
Q3 2020 Dec 14, 2020	BUY	$12.89 - $15.89 $302,915 - $373,415	23,500 Added 65.28%	59,500 $840,000
Q2 2020 Jul 23, 2020	BUY	$8.86 - $15.69 $108,978 - $192,987	12,300 Added 51.9%	36,000 $542,000
Q1 2020 Apr 23, 2020	BUY	$6.63 - $11.16 $89,505 - $150,660	13,500 Added 132.35%	23,700 $218,000
Q3 2019 Oct 21, 2019	SELL	$8.02 - $13.25 $69,774 - $115,275	-8,700 Reduced 46.03%	10,200 $81,000
Q2 2019 Jul 25, 2019	BUY	$10.96 - $14.4 $88,776 - $116,640	8,100 Added 75.0%	18,900 $235,000
Q1 2019 Apr 19, 2019	BUY	$10.04 - $13.92 $69,276 - $96,048	6,900 Added 176.92%	10,800 $146,000
Q4 2018 Jan 23, 2019	BUY	$8.38 - $13.44 $11,732 - $18,816	1,400 Added 56.0%	3,900 $37,000
Q3 2018 Oct 19, 2018	SELL	$11.6 - $16.54 $156,600 - $223,290	-13,500 Reduced 84.38%	2,500 $30,000
Q2 2018 Aug 06, 2018	BUY	$13.13 - $17.09 $51,207 - $66,651	3,900 Added 32.23%	16,000 $249,000
Q1 2018 Apr 20, 2018	BUY	$13.76 - $17.12 $138,976 - $172,912	10,100 Added 505.0%	12,100 $181,000
Q4 2017 Jan 23, 2018	SELL	$12.51 - $16.24 $60,048 - $77,951	-4,800 Reduced 70.59%	2,000 $28,000
Q3 2017 Oct 23, 2017	BUY	$11.74 - $15.78 $79,832 - $107,304	6,800	6,800 $102,000

Others Institutions Holding FOLD

# of Institutions

278

Shares Held

324M

Call Options Held

260K

Put Options Held

261K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account